Company news

Immunovant, Inc. news in 2022

Immunovant, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th

November 6, 2022

Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022

November 3, 2022

Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock

October 3, 2022

Immunovant Announces IMVT-1402, a Next Generation Anti-FcRn

September 27, 2022

Immunovant to Present at Roivant Investor Day on September 28th

September 20, 2022

Immunovant to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14th

September 8, 2022

Immunovant Announces Two New Development Programs for Batoclimab

September 6, 2022

Immunovant to Host Investor Webcast to Announce Two New Indications for Batoclimab on September 7, 2022

August 23, 2022

Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended June 30, 2022

August 4, 2022

Immunovant Achieves Alignment with FDA on Plans for Phase 3 Clinical Trials of Batoclimab in Thyroid Eye Disease and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2022

June 7, 2022

Immunovant to Report Fourth Quarter and Full Year 2022 Financial Results on June 8, 2022

June 5, 2022

Immunovant to Present at the H.C. Wainwright Global Investment Conference on May 25th

May 22, 2022

Immunovant to Present at the UBS Global Healthcare Conference on May 23rd

May 18, 2022

Immunovant to Present at LifeSci Partners’ Immunology and Inflammation Symposium on May 10th

May 3, 2022

Immunovant to Host Virtual R&D Day on March 30, 2022

March 27, 2022

Immunovant to Present at the 11th Annual SVB Leerink Global Healthcare Conference

February 8, 2022

Immunovant Reports Financial Results for the Quarter Ended December 31, 2021

February 3, 2022

Immunovant Appoints Mark Levine as Chief Legal Officer

January 24, 2022

Immunovant to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 6, 2022

Calls in 2022

Decks in 2022